However, the finding of Ghaffari et al. demonstrated that instead of ERα, GPR30 was specifically found mediating the downregulation of SR-B1 and the inhibition of LDL transcytosis to lower the rate of atherosclerosis (56) and ultimately ischemia and CAD/CHD. Here, SCARB1 is linked to coronary artery disorder.